CytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody™ Therapeutic Platform

NEXT STORY
BioSig Announces Expansion of Engineering Team
PREV STORY
Global Medical Tourism Market 2019-2026 – Focus on Turkey, Costa Rica, Thailand, India, Mexico, Singapore, Brazil, Malaysia, Taiwan, Colombia, & South Korea
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference

author_avatar
NASDAQ Market News

Oncternal Therapeutics Announces Updated Interim Data from a Phase 1/2 Study of Cirmtuzumab in Combination with Ibrutinib

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum

author_avatar
NASDAQ Market News